FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan
      Dashboard

      USTR to Conduct Hearing on Section 301 Investigation into Germany's Pharmaceutical Policies

      The Office of the United States Trade Representative (USTR) is set to hold a hearing on September 22, 2026, as part of its Section 301 investigation into the pharmaceutical policies of Germany. This investigation aims to assess whether Germany's practices are unfairly limiting market access for U.S. pharmaceutical products.

      The Section 301 investigation allows the USTR to evaluate foreign trade practices that may harm U.S. interests. The outcome of this hearing could influence future trade relations between the United States and Germany, particularly in the pharmaceutical sector. Stakeholders from various sectors are expected to participate and provide their insights during the hearing.

      © 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

      Source: KLEA News

      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud